Literature DB >> 12024041

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

Latha Shivakumar1, John Minna, Toshiyuki Sakamaki, Richard Pestell, Michael A White.   

Abstract

The RASSF1A locus at 3p21.3 is epigenetically inactivated at high frequency in a variety of solid tumors. Expression of RASSF1A is sufficient to revert the tumorigenicity of human cancer cell lines. We show here that RASSF1A can induce cell cycle arrest by engaging the Rb family cell cycle checkpoint. RASSF1A inhibits accumulation of native cyclin D1, and the RASSF1A-induced cell cycle arrest can be relieved by ectopic expression of cyclin D1 or of other downstream activators of the G(1)/S-phase transition (cyclin A and E7). Regulation of cyclin D1 is responsive to native RASSF1A activity, because RNA interference-mediated downregulation of endogenous RASSF1A expression in human epithelial cells results in abnormal accumulation of cyclin D1 protein. Inhibition of cyclin D1 by RASSF1A occurs posttranscriptionally and is likely at the level of translational control. Rare alleles of RASSF1A, isolated from tumor cell lines, encode proteins that fail to block cyclin D1 accumulation and cell cycle progression. These results strongly suggest that RASSF1A is an important human tumor suppressor protein acting at the level of G(1)/S-phase cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024041      PMCID: PMC133879          DOI: 10.1128/MCB.22.12.4309-4318.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis.

Authors:  M D Vos; C A Ellis; A Bell; M J Birrer; G J Clark
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 2.  Integrins and anoikis.

Authors:  S M Frisch; E Ruoslahti
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

3.  Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.

Authors:  J A Diehl; F Zindy; C J Sherr
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

4.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

5.  Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.

Authors:  R Dammann; G Yang; G P Pfeifer
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

6.  Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.

Authors:  B Dufourny; I H Hamelers; J S Sussenbach; P H Steenbergh
Journal:  J Endocrinol       Date:  2000-08       Impact factor: 4.286

7.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 8.  Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.

Authors:  K Kok; S L Naylor; C H Buys
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

Review 9.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 10.  Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression.

Authors:  R K Assoian; M A Schwartz
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

View more
  109 in total

1.  The RASSF1A tumor suppressor regulates XPA-mediated DNA repair.

Authors:  Howard Donninger; Jennifer Clark; Francesca Rinaldo; Nicholas Nelson; Thibaut Barnoud; M Lee Schmidt; Katharine R Hobbing; Michele D Vos; Brian Sils; Geoffrey J Clark
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma.

Authors:  Javad Mohammadi-asl; Bagher Larijani; Zhamak Khorgami; Seyed Mohammad Tavangar; Vahid Haghpanah; Majid Kheirollahi; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-06-10       Impact factor: 3.064

Review 3.  Regulation of mammalian Ste20 (Mst) kinases.

Authors:  Sonali J Rawat; Jonathan Chernoff
Journal:  Trends Biochem Sci       Date:  2015-02-06       Impact factor: 13.807

Review 4.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.

Authors:  Wen-Jing Shen; Dong-Qiu Dai; Yue Teng; Hong-Bo Liu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

6.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

7.  Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.

Authors:  Mei Yi; Wei Wang; Shengnan Chen; Ya Peng; Junjun Li; Jing Cai; Ying Zhou; Qian Peng; Yuanyuan Ban; Zhaoyang Zeng; Xiaoling Li; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  Mol Biol Rep       Date:  2018-08-03       Impact factor: 2.316

Review 8.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

9.  ATM regulates a RASSF1A-dependent DNA damage response.

Authors:  Garth Hamilton; Karen S Yee; Simon Scrace; Eric O'Neill
Journal:  Curr Biol       Date:  2009-12-03       Impact factor: 10.834

Review 10.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.